RMD Resmed Inc

  1. Stocks
  2. Healthcare
  3. NYSE: RMD

Price (delayed)

$238.99

Market cap

$33.62B

P/E Ratio

21.71

Dividend/share

$2.46

EPS

$11.01

Enterprise value

$33.22B

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 91

At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies ...

Highlights
Resmed's debt has decreased by 28% YoY and by 26% QoQ
The EPS has increased by 12% YoY and by 5% from the previous quarter
The price to earnings (P/E) is 33% lower than the 5-year quarterly average of 32.1 but 3.1% higher than the last 4 quarters average of 21.0
Resmed's quick ratio has decreased by 18% YoY and by 17% from the previous quarter
RMD's equity is down by 10% since the previous quarter and by 2.8% year-on-year
Sector: Healthcare
Industry: Medical Instruments & Supplies
Website: http://www.resmed.com
Peers: MDT TMO ELMD INGN

Key stats

What are the main financial stats of RMD

RMD stock price

How has the Resmed stock price performed over time
Intraday
0.19%
1 week
-0.13%
1 month
1.87%
1 year
-5.49%
YTD
-0.78%
QTD
8.09%

Financial performance

How have Resmed's revenue and profit performed over time
Revenue
$5.73B
Gross profit
$3.5B
Operating income
$1.89B
Net income
$1.59B
Gross margin
61.1%
Net margin
27.8%
RMD's net income is up by 11% YoY and by 4.6% QoQ
The gross profit has grown by 11% YoY
The company's revenue rose by 9% YoY
RMD's operating income is up by 9% YoY

Price vs fundamentals

How does RMD's price correlate with its fundamentals

Growth

What is Resmed's growth rate over time

Valuation

What is Resmed stock price valuation
RMD P/E details
P/E
21.71
P/B
5.8
P/S
5.96
EV/EBIT
16.4
EV/EBITDA
14.67
EV/Sales
5.79
The price to earnings (P/E) is 33% lower than the 5-year quarterly average of 32.1 but 3.1% higher than the last 4 quarters average of 21.0
The EPS has increased by 12% YoY and by 5% from the previous quarter
RMD's P/B is 17% below its 5-year quarterly average of 7.0 but 14% above its last 4 quarters average of 5.1
RMD's equity is down by 10% since the previous quarter and by 2.8% year-on-year
The P/S is 17% lower than the 5-year quarterly average of 7.2 but 4.4% higher than the last 4 quarters average of 5.7
The company's revenue rose by 9% YoY

Efficiency

How efficient is Resmed business performance
The company's return on invested capital rose by 15% YoY and by 4.6% QoQ
The ROS has increased by 6% YoY and by 3.8% from the previous quarter
Resmed's ROE has increased by 5% from the previous quarter
The ROA has increased by 5% from the previous quarter

Dividends

What is RMD's dividend history
Dividend details
DPS
$2.46
Dividend yield
1.03%
Payout ratio
22.3%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Resmed financials performed over time
Resmed's quick ratio has decreased by 18% YoY and by 17% from the previous quarter
The current ratio has contracted by 15% from the previous quarter and by 8% YoY
Resmed's debt is 90% lower than its equity
Resmed's debt to equity has decreased by 29% YoY and by 23% QoQ
Resmed's debt has decreased by 28% YoY and by 26% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.